2. Growing Diabetes Pandemic Worldwide

3. Approved Antidiabetic Medications

5. Cardiovascular Benefits to Tighter HbA1c Control?

7. UKPDS 10-Year Follow-Up

9. Effects of More- vs Less-Intensive Glycemic Control

10. Sulfonylureas and CV Mortality

11. Summary of RCT and Meta-Analysis Data on Thiazolidinediones and Myocardial Infarction Risk

12. Incretin-based Drugs

13. DPP4i Cardiovascular Meta-Analysis

14. EXAMINE

15. SAVOR-TIMI 53 Summary

16. SAVOR-TIMI 53 Summary

17. SGLT2 Inhibition: Novel Mechanism

19. ADVANCE Trial: Systolic Blood Pressure at the End of Follow-Up Period

20. ACCORD BP

21. Benefits of Statins in Diabetes

22. STENO-2: Multifactorial Approach To Improve CV Outcomes in T2D

23. Mean Changes in Weight, Fitness, and Cardiovascular Disease Risk Factors in Intensive Lifestyle Intervention (ILI) and Diabetes Support and Education (DES) Groups and the Difference Between Groups Averaged Across 4 Years

26. Summary

27. Abbreviations

28. Abbreviations (cont)

29. Abbreviations (cont)

30. References

31. References (cont)

32. References (cont)

33. References (cont)